Literature DB >> 11069891

Requirement for Atr in phosphorylation of Chk1 and cell cycle regulation in response to DNA replication blocks and UV-damaged DNA in Xenopus egg extracts.

Z Guo1, A Kumagai, S X Wang, W G Dunphy.   

Abstract

The checkpoint kinase Xchk1 becomes phosphorylated in Xenopus egg extracts in response to DNA replication blocks or UV-damaged DNA. Xchk1 is also required for the cell cycle delay that is induced by unreplicated or UV-damaged DNA. In this report, we have removed the Xenopus homolog of ATR (Xatr) from egg extracts by immunodepletion. In Xatr-depleted extracts, the checkpoint-associated phosphorylation of Xchk1 is abolished, and the cell cycle delay induced by replication blocks is strongly compromised. Xatr from egg extracts phosphorylated recombinant Xchk1 in vitro, but not a mutant form of Xchk1 (Xchk1-4AQ) containing nonphosphorylatable residues in its four conserved SQ/TQ motifs. Recombinant human ATR, but not a kinase-inactive mutant, phosphorylated the same sites in Xchk1. Furthermore, the Xchk1-4AQ mutant was found to be defective in mediating a checkpoint response in egg extracts. These findings suggest that Xchk1 is a functionally important target of Xatr during a checkpoint response to unreplicated or UV-damaged DNA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11069891      PMCID: PMC317027          DOI: 10.1101/gad.842500

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  60 in total

Review 1.  Quality control by DNA repair.

Authors:  T Lindahl; R D Wood
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

2.  ATR is a caffeine-sensitive, DNA-activated protein kinase with a substrate specificity distinct from DNA-PK.

Authors:  C A Hall-Jackson; D A Cross; N Morrice; C Smythe
Journal:  Oncogene       Date:  1999-11-18       Impact factor: 9.867

3.  Isolation and characterization of Xenopus ATM (X-ATM): expression, localization, and complex formation during oogenesis and early development.

Authors:  K Robertson; C Hensey; J Gautier
Journal:  Oncogene       Date:  1999-11-25       Impact factor: 9.867

4.  Role of human Cds1 (Chk2) kinase in DNA damage checkpoint and its regulation by p53.

Authors:  K Tominaga; H Morisaki; Y Kaneko; A Fujimoto; T Tanaka; M Ohtsubo; M Hirai; H Okayama; K Ikeda; M Nakanishi
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

5.  Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks.

Authors:  D Cortez; Y Wang; J Qin; S J Elledge
Journal:  Science       Date:  1999-11-05       Impact factor: 47.728

6.  The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites.

Authors:  S Y Shieh; J Ahn; K Tamai; Y Taya; C Prives
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

7.  Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53.

Authors:  N H Chehab; A Malikzay; M Appel; T D Halazonetis
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

8.  ATR disruption leads to chromosomal fragmentation and early embryonic lethality.

Authors:  E J Brown; D Baltimore
Journal:  Genes Dev       Date:  2000-02-15       Impact factor: 11.361

9.  Substrate specificities and identification of putative substrates of ATM kinase family members.

Authors:  S T Kim; D S Lim; C E Canman; M B Kastan
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

10.  Vectors for the inducible overexpression of glutathione S-transferase fusion proteins in yeast.

Authors:  D A Mitchell; T K Marshall; R J Deschenes
Journal:  Yeast       Date:  1993-07       Impact factor: 3.239

View more
  173 in total

1.  ATR inhibition selectively sensitizes G1 checkpoint-deficient cells to lethal premature chromatin condensation.

Authors:  P Nghiem; P K Park; Y Kim ; C Vaziri; S L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

2.  Preferential binding of ATR protein to UV-damaged DNA.

Authors:  Keziban Unsal-Kaçmaz; Alexander M Makhov; Jack D Griffith; Aziz Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

3.  Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance.

Authors:  Eric J Brown; David Baltimore
Journal:  Genes Dev       Date:  2003-03-01       Impact factor: 11.361

4.  Regulation of Chk1 kinase by autoinhibition and ATR-mediated phosphorylation.

Authors:  Yoshinori Katsuragi; Noriyuki Sagata
Journal:  Mol Biol Cell       Date:  2004-02-06       Impact factor: 4.138

5.  Regulation of checkpoint kinases through dynamic interaction with Crb2.

Authors:  Satoru Mochida; Fumiko Esashi; Nobuki Aono; Katsuyuki Tamai; Matthew J O'Connell; Mitsuhiro Yanagida
Journal:  EMBO J       Date:  2004-01-22       Impact factor: 11.598

6.  A requirement for replication in activation of the ATR-dependent DNA damage checkpoint.

Authors:  Patrick J Lupardus; Tony Byun; Muh-Ching Yee; Mohammad Hekmat-Nejad; Karlene A Cimprich
Journal:  Genes Dev       Date:  2002-09-15       Impact factor: 11.361

7.  Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism.

Authors:  Katsuhiro Uto; Daigo Inoue; Ken Shimuta; Nobushige Nakajo; Noriyuki Sagata
Journal:  EMBO J       Date:  2004-07-22       Impact factor: 11.598

8.  Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2.

Authors:  Harry A Rogoff; Mary T Pickering; Fiona M Frame; Michelle E Debatis; Yolanda Sanchez; Stephen Jones; Timothy F Kowalik
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

9.  Chk1 promotes replication fork progression by controlling replication initiation.

Authors:  Eva Petermann; Mick Woodcock; Thomas Helleday
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

Review 10.  Clinically Applicable Inhibitors Impacting Genome Stability.

Authors:  Anu Prakash; Juan F Garcia-Moreno; James A L Brown; Emer Bourke
Journal:  Molecules       Date:  2018-05-13       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.